UBS Reports Early Signs of GenAI Monetization at Meta

UBS analyst Stephen Ju reiterated a Buy rating and $865.00 price target for Meta Platforms Inc. (NASDAQ: META), citing early signs that the company is monetizing its Generative AI-enabled 'Business Agent' chatbot, following its expansion to businesses globally during Conversations 2026.

By Ghazal Ahmed Mon, June 8, 2026 at 3:49 PM GMT+3 2 min read · Yahoo Finance · June 8, 2026, 12:49 UTC

UBS Reports Early Signs of GenAI Monetization at Meta

Tickers: $META $MSFT $QCOM

Topics: AI stocks GenAI monetization Meta UBS analysis

Read the full article at Yahoo Finance

More World news

Tesla to Discontinue Cybertruck Production by Summer 2027 to Prioritize Cybercab The Verge · November 12, 2026, 17:00 UTC
Absci Reports Q3 2026 Financial Results and Clinical Updates for ABS-201 Motley Fool · November 12, 2026, 16:54 UTC
Acurx Pharmaceuticals Reports Q3 2026 Financial Results and Initiates PATHFINDER Trial Enrollment Motley Fool · November 12, 2026, 16:54 UTC
Fermi Inc. Reports Q3 2026 Net Loss of $141.6 Million Amid Infrastructure Expansion Motley Fool · November 12, 2026, 16:54 UTC
Google Wallet Introduces Digital Home Key Support via Aliro Standard The Verge · November 12, 2026, 16:56 UTC
Analyst Ming-Chi Kuo Suggests Nvidia CEO Resignation May Have Limited Near-Term Stock Impact Seeking Alpha · November 12, 2026, 16:53 UTC
Solo Brands Lowers Net Sales Outlook While Projecting 2026 Adjusted EBITDA Growth Seeking Alpha · November 12, 2026, 16:50 UTC
EyePoint Pharmaceuticals Announces Strategic Shift to DURAVYU DME Following Phase III Wet AMD Trial Failures Seeking Alpha · November 12, 2026, 16:50 UTC
Apple to Update HomeView Software Following Feedback on Voice Command Limitations The Verge · November 12, 2026, 16:53 UTC
Endeavour Mining Shares Drop Following Production Warning at Mana Gold Mine Seeking Alpha · November 12, 2026, 16:48 UTC